Bibliography
Export 36 results:
Filters: Keyword is Registries [Clear All Filters]
Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod. 2010;25(8):1851-62.
Heritable disease and sperm donation. JAMA. 2010;303(7):617-8; - author - reply - 618-9.
Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica. 2008;93(5):735-40.
Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;14(9 Suppl):29-36.
Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation. 2007;84(2):272-4.
Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol Dial Transplant. 2007;22 Suppl 8:viii29-viii36.
Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy. Transplant Proc. 2006;38(2):358-61.
Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc. 2005;37(2):583-4.
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
Donor kidneys with small renal cell cancers: can they be transplanted? Transplant Proc. 2005;37(2):581-2.
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954-5.
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum. 2004;47(11):1898-903.
Donor transmitted malignancies. Ann Transplant. 2004;9(1):53-6.
De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy. Transplant Proc. 2002;34(5):1784-5.
Incidental diagnosis of gastric cancer in transplant recipients improves patient survival. Surgery. 2002;132(4):754-8; - discussion - 758-60.
Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant. J Neurol Neurosurg Psychiatry. 2001;71(6):818.
National survey of hemapheresis practice in Turkey (1998). Transfusion Science. 2000;22(3):195-201.
Some problems with posttransplant lymphoproliferative disease. Transplantation. 2000;69(5):705-6.
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. Jama. 1998;280(13):1153-60.
Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1998:147-58.
Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997;90(3):903-8.